Jack Liu

Jack Liu, PhD, is a Senior Research Analyst at 5AM Ventures in Boston, MA, where he specializes in investment research and due diligence focused on the biotechnology and life sciences sectors. In his current role, Dr. Liu leverages deep technical expertise to identify and evaluate emerging companies with high-impact potential in healthcare innovation, particularly early-stage biotech and therapeutic ventures aligned with 5AM's investment strategy.

Prior to joining 5AM Ventures in 2023, Dr. Liu served as Vice President of Research at Tekla Capital Management and as an Equity Analyst at Weatherbie Capital, LLC, where he honed his investment acumen covering a wide range of companies in the healthcare and biopharma industries. These roles enabled him to develop strong sector insight and hands-on experience in both private and public market analysis.

Dr. Liu holds a Doctor of Philosophy from Northeastern University, a Master's in Business Administration with a concentration in Finance from MIT Sloan School of Management, and a Bachelor's degree from Tsinghua University. His rigorous academic training and extensive industry experience have contributed to his notable track record in identifying transformative opportunities within the biotechnology and life science asset classes.